Cargando…

Oxaliplatin‐ and docetaxel‐induced polyneuropathy: clinical and neurophysiological characteristics

The aim of this study was to evaluate the presence and characterization of chemotherapy‐induced neuropathy (CIPN) and neuropathic pain 5 years after adjuvant chemotherapy with docetaxel or oxaliplatin. Patients from an ongoing prospective study, who had received adjuvant chemotherapy with docetaxel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bennedsgaard, Kristine, Ventzel, Lise, Andersen, Niels T., Themistocleous, Andreas C., Bennett, David L., Jensen, Troels S., Tankisi, Hatice, Finnerup, Nanna B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Periodicals, Inc. 2020
Materias:	Research Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756561/ https://www.ncbi.nlm.nih.gov/pubmed/32902058 http://dx.doi.org/10.1111/jns.12413

Ejemplares similares

Long‐term symptoms of polyneuropathy in breast and colorectal cancer patients treated with and without adjuvant chemotherapy
por: Bennedsgaard, Kristine, et al.
Publicado: (2020)

Cold aggravates abnormal excitability of motor axons in oxaliplatin‐treated patients
por: Bennedsgaard, Kristine, et al.
Publicado: (2020)

Axonal Excitability Does Not Differ between Painful and Painless Diabetic or Chemotherapy‐Induced Distal Symmetrical Polyneuropathy in a Multicenter Observational Study
por: Themistocleous, Andreas C., et al.
Publicado: (2022)

The characteristics of pain and dysesthesia in patients with diabetic polyneuropathy
por: Gylfadottir, Sandra Sif, et al.
Publicado: (2022)

Analysis of Macrophages and Peptidergic Fibers in the Skin of Patients With Painful Diabetic Polyneuropathy
por: Gylfadottir, Sandra Sif, et al.
Publicado: (2021)

Axonal swellings are related to type 2 diabetes, but not to distal diabetic sensorimotor polyneuropathy
por: Karlsson, Pall, et al.
Publicado: (2021)

Comparison of diabetic and idiopathic sensory polyneuropathies with respect to nerve fibre affection and risk factors
por: Itani, Mustapha, et al.
Publicado: (2022)

Diabetic polyneuropathy and pain, prevalence, and patient characteristics: a cross-sectional questionnaire study of 5,514 patients with recently diagnosed type 2 diabetes
por: Gylfadottir, Sandra Sif, et al.
Publicado: (2020)

Clinical neurophysiological tests as objective measures for acute and long-term COVID-19
por: Seeck, Margitta, et al.
Publicado: (2022)

Can diabetic polyneuropathy and foot ulcers in patients with type 2 diabetes be accurately identified based on ICD-10 hospital diagnoses and drug prescriptions?
por: Christensen, Diana Hedevang, et al.
Publicado: (2019)

Clinical use of pregabalin in the management of central neuropathic pain
por: Finnerup, Nanna B, et al.
Publicado: (2007)

Long-COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Potential neurophysiological biomarkers for these enigmatic entities
por: Versace, Viviana, et al.
Publicado: (2023)

The impact of vestibular dysfunction on falls and postural instability in individuals with type 2 diabetes with and without diabetic polyneuropathy
por: Jørgensen, Ina Ejsing Hunnerup, et al.
Publicado: (2023)

Plasma lipid metabolites associate with diabetic polyneuropathy in a cohort with type 2 diabetes
por: Rumora, Amy E., et al.
Publicado: (2021)

Pain Following Stroke: A Population-Based Follow-Up Study
por: Klit, Henriette, et al.
Publicado: (2011)

Evidence-based recommendations for examination and diagnostic strategies of polyneuropathy electrodiagnosis
por: Tankisi, H., et al.
Publicado: (2019)

Painful and non‐painful diabetic polyneuropathy: Clinical characteristics and diagnostic issues
por: Gylfadottir, Sandra Sif, et al.
Publicado: (2019)

Critical illness myopathy and polyneuropathy in Covid-19: Is it a distinct entity?
por: Tankisi, H.
Publicado: (2021)

Recent advances in pharmacological treatment of neuropathic pain
por: Finnerup, Nanna Brix, et al.
Publicado: (2010)

Dorsal root ganglia hypertrophy as in vivo correlate of oxaliplatin-induced polyneuropathy
por: Apostolidis, Leonidas, et al.
Publicado: (2017)

Effect of lacosamide in peripheral neuropathic pain: study protocol for a randomized, placebo-controlled, phenotype-stratified trial
por: Carmland, Malin E., et al.
Publicado: (2019)

Randomised Controlled Trials May Underestimate Drug Effects: Balanced Placebo Trial Design
por: Lund, Karen, et al.
Publicado: (2014)

Critical illness polyneuropathy (CIP) in neurological early rehabilitation: clinical and neurophysiological features
por: Schmidt, Simone B., et al.
Publicado: (2016)

Delta and gamma oscillations in operculo-insular cortex underlie innocuous cold thermosensation
por: Fardo, Francesca, et al.
Publicado: (2017)

Peripheral polyneuropathy from electrodiagnostic tests: a 10-year etiology and neurophysiology overview
por: Ducci, Renata Dal-Prá, et al.
Publicado: (2021)

Irinotecan, docetaxel and oxaliplatin combination in metastatic gastric or gastroesophageal junction adenocarcinoma
por: Di Lauro, L, et al.
Publicado: (2007)

Alterations of retinal thickness measured by optical coherence tomography correlate with neurophysiological measures in diabetic polyneuropathy
por: Yamada, Yuichiro, et al.
Publicado: (2020)

A brain-based pain facilitation mechanism contributes to painful diabetic polyneuropathy
por: Segerdahl, Andrew R, et al.
Publicado: (2018)

Functional and structural markers of peripheral microvascular autonomic neuropathy
por: Rasmussen, Thorsten K., et al.
Publicado: (2022)

Ala97Ser transthyretin amyloidosis-associated polyneuropathy, clinical and neurophysiological profiles in a Thai cohort
por: Pasutharnchat, Nath, et al.
Publicado: (2021)

Docetaxel, Oxaliplatin and Capecitabine (TEX) triplet regimen as adjuvant chemotherapy in resected gastric adenocarcinoma
por: Thumaty, Divya Bala, et al.
Publicado: (2021)

Normative reference values for the dorsal sural nerve derived from a large multicenter cohort
por: Krøigård, Thomas, et al.
Publicado: (2021)

Structural Changes of Cutaneous Immune Cells in Patients With Type 1 Diabetes and Their Relationship With Diabetic Polyneuropathy
por: Hu, Xiaoli, et al.
Publicado: (2023)

Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma
por: Di Lauro, Luigi, et al.
Publicado: (2009)

Efficacy and Safety of Docetaxel Plus Oxaliplatin and Capecitabine in the First Line Treatment of Advanced Gastric Adenocarcinoma
por: Liu, Ying, et al.
Publicado: (2013)

Long Term Complete Remission in Advanced Gastric Adenocarcinoma With Docetaxel, Oxaliplatin and Capecitabine Combination Regimen
por: Goel, Gaurav
Publicado: (2012)

The test–retest reliability of large and small fiber nerve excitability testing with threshold tracking
por: Pia, Hossein, et al.
Publicado: (2023)

Falls and fractures associated with type 2 diabetic polyneuropathy: A cross‐sectional nationwide questionnaire study
por: Khan, Karolina Snopek, et al.
Publicado: (2021)

Clinical benefits of combined chemotherapy with S-1, oxaliplatin, and docetaxel in advanced gastric cancer patients with palliative surgery
por: Liu, Yan, et al.
Publicado: (2016)

Efficacy after preoperative capecitabine and oxaliplatin (XELOX) versus docetaxel, oxaliplatin and S1 (DOS) in patients with locally advanced gastric adenocarcinoma: a propensity score matching analysis
por: Wang, Yan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5rh3fnbep25u1nq0d192kleoo5